The Marcus Corporation Reports Second Quarter Fiscal 2022 Results and Reinstates Quarterly Dividend
The Marcus Corporation (NYSE: MCS) reported strong second quarter fiscal 2022 results, with revenues rising to $198.6 million, a 114.5% increase year-over-year. Operating income surged to $18.9 million, marking a return to profitability after a $26.1 million loss in the same quarter last year. Net earnings were $9.0 million, up from a net loss of $23.4 million. Adjusted EBITDA reached $37.3 million compared to a loss of $1.2 million in the previous year. The company declared a cash dividend of $0.05 per share, its first since March 2020, reflecting a commitment to return value to shareholders.
- Total revenues increased 114.5% year-over-year to $198.6 million.
- Operating income improved to $18.9 million from a $26.1 million loss last year.
- Net earnings of $9.0 million compared to a net loss of $23.4 million in the prior year.
- Adjusted EBITDA rose to $37.3 million from a loss of $1.2 million.
- First cash dividend of $0.05 per share since March 2020, indicating strong liquidity.
- Net loss of $5.9 million for the first half of fiscal 2022 compared to a loss of $51.5 million last year.
Both Divisions Contribute to Strong Operating Performance and Liquidity
Leading to First Cash Dividend Post-Pandemic
“This was our strongest quarter in recent years, with significant improvements in revenue, operating income and Adjusted EBITDA,” said
Second Quarter Fiscal 2022 Highlights
-
Total revenues for the second quarter of fiscal 2022 were
, a$198.6 million 114.5% increase from total revenues of for the second quarter of fiscal 2021.$92.5 million
-
Operating income was
for the second quarter of fiscal 2022, compared to operating loss of$18.9 million for the prior year quarter.$26.1 million
-
Net earnings attributable to
The Marcus Corporation was for the second quarter of fiscal 2022, compared to net loss attributable to$9.0 million The Marcus Corporation of for the same period in fiscal 2021.$23.4 million
-
Net earnings per diluted common share attributable to
The Marcus Corporation was for the second quarter of fiscal 2022, compared to net loss per diluted common share attributable to$0.24 The Marcus Corporation of for the second quarter of fiscal 2021.$0.76
-
Adjusted EBITDA was
for the second quarter of fiscal 2022, compared to a loss of$37.3 million for the prior year quarter.$1.2 million
-
On
July 29, 2022 , the Board of Directors ofThe Marcus Corporation declared a regular quarter cash dividend of per share of common stock, to be paid$0.05 September 15, 2022 , to shareholders of record onAugust 25, 2022 . The Board of Directors also declared a dividend of per share of Class B common stock, to be paid$0.04 5September 15, 2022 , to shareholders of record as ofAugust 25, 2022 .
Adjusted EBITDA reflects an adjustment made by the company to eliminate the impact of noncash impairment charges during the second quarter of fiscal 2021.
First Half Fiscal 2022 Highlights
-
Total revenues for the first half of fiscal 2022 were
, a$330.8 million 130.8% increase from total revenues of for the first half of fiscal 2021.$143.3 million
-
Operating income was
for the first half of fiscal 2022, compared to operating loss of$2.1 million for the first half of fiscal 2021.$61.8 million
-
Net loss attributable to
The Marcus Corporation was for the first half of fiscal 2022, compared to net loss attributable to$5.9 million The Marcus Corporation of for the same period in fiscal 2021.$51.5 million
-
Net loss per diluted common share attributable to
The Marcus Corporation was for the first half of fiscal 2022, compared to net loss per diluted common share attributable to$0.19 The Marcus Corporation of for the first half of fiscal 2021.$1.71
-
Adjusted EBITDA was
for the first half of fiscal 2022, compared to a loss of$40.7 million for the first half of fiscal 2021.$18.7 million
Adjusted EBITDA reflects an adjustment made by the company to eliminate the impact of noncash impairment charges and the favorable impact of a nonrecurring state government grant during the first half of fiscal 2021.
Revenue and operating income for
For the second quarter of fiscal 2022, increases in both attendance and revenue per person compared to the prior year period contributed to the fourth straight quarter of positive Adjusted EBITDA for
“The second quarter of fiscal 2022 mirrored the famous movie line ‘if you build it, he will come.’ The sensational performance of Top Gun: Maverick was among the highest grossing box office films ever released, yet the blockbuster story of the second quarter of fiscal 2022 was the increased quantity of appealing film releases that drove moviegoers of all ages to the theatres,” said
Marcus Theatres’ top five highest-performing films in the second quarter of fiscal 2022 were Top Gun: Maverick, Doctor Strange in the Multiverse of Madness,
During the second quarter of fiscal 2022,
Revenue per available room (RevPAR) increased at all eight company owned properties during the second quarter and first half of fiscal 2022, with
“Comparable hotel division revenues during the second quarter of fiscal 2022 were 99 percent of pre-pandemic second quarter fiscal 2019 results, demonstrating the impressive pace of our recovery, which has exceeded expectations,” said
While the leisure travel market continues to drive demand, business travel continues to increase as corporate training events, meetings and conferences return and downtown offices reopen. Group booking pace for fiscal 2022 continues to improve since the first quarter of fiscal 2022 with group booking activity increasing for fiscal 2022 and into 2023. Increases in corporate group, event and wedding bookings contributed to improved banquet and catering revenue in the quarter.
Balance Sheet and Liquidity
The Marcus Corporation’s financial position remains strong with
On
“The early retirement of our term loan with cash flow generated from operations in the second quarter and the dividend announced today reflect our confidence in our strong liquidity position and the significant progress that has been made in our post-pandemic recovery,” said
Diluted weighted average shares outstanding and diluted net earnings per common share include the dilutive effect of conversion of the Company’s convertible notes to the extent conversion is dilutive in each period. During the second quarter of fiscal 2022 diluted weighted average shares outstanding includes 9.1 million shares from the dilutive effect of the convertible notes, which were excluded from diluted weighted average shares outstanding in the other periods presented as the convertible notes were antidilutive. Diluted weighted average shares outstanding does not include the benefit from the capped call transactions the Company entered into in connection with the issuance of the convertible notes, which mitigate the dilutive effect of the convertible notes by approximately 2.6 million shares during the second quarter of fiscal 2022. Upon conversion, the convertible notes may be settled, at the Company’s election, in cash, shares of common stock or a combination thereof.
Conference Call and Webcast
A telephone replay of the conference call will be available through
Non-GAAP Financial Measure
Adjusted EBITDA has been presented in this press release as a supplemental measure of financial performance that is not required by, or presented in accordance with, GAAP. The company defines Adjusted EBITDA as net earnings (loss) attributable to
Adjusted EBITDA is a key measure used by management and the company’s board of directors to assess the company’s financial performance and enterprise value. The company believes that Adjusted EBITDA is a useful measure, as it eliminates certain expenses and gains that are not indicative of the company’s core operating performance and facilitates a comparison of the company’s core operating performance on a consistent basis from period to period. The company also uses Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of its business strategies, to make budgeting decisions, and to compare its performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.
Adjusted EBITDA is a non-GAAP measure of the company’s financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP and it should not be construed as an inference that the company’s future results will be unaffected by unusual or non-recurring items. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. In addition, this non-GAAP measure excludes certain non-recurring and other charges and has its limitations as an analytical tool. You should not consider Adjusted EBITDA in isolation or as a substitute for analysis of the company’s results as reported under GAAP. In evaluating Adjusted EBITDA, you should be aware that in the future the company will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. The company’s presentation of Adjusted EBITDA should not be construed to imply that the company’s future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by the company may not be comparable to the measures disclosed by other companies.
About
Headquartered in
Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects of the COVID-19 pandemic on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the duration of the COVID-19 pandemic and related government restrictions and the level of customer demand following the relaxation of such requirements; (3) the availability, in terms of both quantity and audience appeal, of certain motion pictures for our theatre division (particularly following the COVID-19 pandemic, during which the release dates for motion pictures have been postponed), as well as other industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets, including but not limited to, those caused by the COVID-19 pandemic; (5) the effects of adverse economic conditions, including but not limited to, those caused by the COVID-19 pandemic, on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the COVID-19 pandemic and the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (12) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (13) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in
Consolidated Statements of Earnings (Loss) (Unaudited) (in thousands, except per share data) |
||||||||||||||||
|
13 Weeks Ended |
|
26 Weeks Ended |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Revenues: |
|
|
|
|
|
|
|
|||||||||
Theatre admissions |
$ |
63,087 |
|
|
$ |
24,915 |
|
|
$ |
101,504 |
|
|
$ |
35,600 |
|
|
Rooms |
|
28,865 |
|
|
|
17,332 |
|
|
|
46,295 |
|
|
|
26,376 |
|
|
Theatre concessions |
|
58,147 |
|
|
|
23,061 |
|
|
|
93,611 |
|
|
|
32,980 |
|
|
Food and beverage |
|
19,014 |
|
|
|
9,591 |
|
|
|
33,525 |
|
|
|
15,503 |
|
|
Other revenues |
|
21,192 |
|
|
|
14,231 |
|
|
|
39,999 |
|
|
|
26,125 |
|
|
|
|
190,305 |
|
|
|
89,130 |
|
|
|
314,934 |
|
|
|
136,584 |
|
|
Cost reimbursements |
|
8,250 |
|
|
|
3,417 |
|
|
|
15,863 |
|
|
|
6,750 |
|
|
Total revenues |
|
198,555 |
|
|
|
92,547 |
|
|
|
330,797 |
|
|
|
143,334 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Costs and expenses: |
|
|
|
|
|
|
|
|||||||||
Theatre operations |
|
61,737 |
|
|
|
28,877 |
|
|
|
106,165 |
|
|
|
47,147 |
|
|
Rooms |
|
10,471 |
|
|
|
7,072 |
|
|
|
18,674 |
|
|
|
12,337 |
|
|
Theatre concessions |
|
22,993 |
|
|
|
10,037 |
|
|
|
38,186 |
|
|
|
14,533 |
|
|
Food and beverage |
|
15,035 |
|
|
|
7,806 |
|
|
|
27,175 |
|
|
|
13,176 |
|
|
Advertising and marketing |
|
5,978 |
|
|
|
3,819 |
|
|
|
10,459 |
|
|
|
6,368 |
|
|
Administrative |
|
17,627 |
|
|
|
15,963 |
|
|
|
36,708 |
|
|
|
29,279 |
|
|
Depreciation and amortization |
|
16,752 |
|
|
|
18,494 |
|
|
|
33,983 |
|
|
|
36,473 |
|
|
Rent |
|
6,578 |
|
|
|
6,344 |
|
|
|
12,828 |
|
|
|
12,685 |
|
|
Property taxes |
|
4,980 |
|
|
|
4,468 |
|
|
|
9,725 |
|
|
|
9,207 |
|
|
Other operating expenses |
|
9,261 |
|
|
|
8,628 |
|
|
|
18,935 |
|
|
|
13,418 |
|
|
Impairment charges |
|
— |
|
|
|
3,732 |
|
|
|
— |
|
|
|
3,732 |
|
|
Reimbursed costs |
|
8,250 |
|
|
|
3,417 |
|
|
|
15,863 |
|
|
|
6,750 |
|
|
Total costs and expenses |
|
179,662 |
|
|
|
118,657 |
|
|
|
328,701 |
|
|
|
205,105 |
|
|
|
|
|
|
|
|
|
|
|||||||||
Operating income (loss) |
|
18,893 |
|
|
|
(26,110 |
) |
|
|
2,096 |
|
|
|
(61,771 |
) |
|
|
|
|
|
|
|
|
|
|||||||||
Other income (expense): |
|
|
|
|
|
|
|
|||||||||
Investment income (loss) |
|
(459 |
) |
|
|
120 |
|
|
|
(727 |
) |
|
|
160 |
|
|
Interest expense |
|
(4,063 |
) |
|
|
(4,907 |
) |
|
|
(8,155 |
) |
|
|
(9,750 |
) |
|
Other income (expense) |
|
(584 |
) |
|
|
(628 |
) |
|
|
(1,161 |
) |
|
|
(1,256 |
) |
|
Gain (loss) on disposition of property, equipment and other assets |
|
(69 |
) |
|
|
(164 |
) |
|
|
355 |
|
|
|
2,040 |
|
|
Equity earnings (losses) from unconsolidated joint ventures |
|
7 |
|
|
|
— |
|
|
|
(134 |
) |
|
|
— |
|
|
|
|
(5,168 |
) |
|
|
(5,579 |
) |
|
|
(9,822 |
) |
|
|
(8,806 |
) |
|
|
|
|
|
|
|
|
|
|||||||||
Earnings (loss) before income taxes |
|
13,725 |
|
|
|
(31,689 |
) |
|
|
(7,726 |
) |
|
|
(70,577 |
) |
|
Income tax expense (benefit) |
|
4,765 |
|
|
|
(8,323 |
) |
|
|
(1,784 |
) |
|
|
(19,081 |
) |
|
Net earnings (loss) |
|
8,960 |
|
|
|
(23,366 |
) |
|
|
(5,942 |
) |
|
|
(51,496 |
) |
|
Net earnings (loss) attributable to noncontrolling interests |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Net earnings (loss) attributable to |
$ |
8,960 |
|
|
$ |
(23,366 |
) |
|
$ |
(5,942 |
) |
|
$ |
(51,496 |
) |
|
|
|
|
|
|
|
|
|
|||||||||
Net earnings (loss) per common share attributable to |
|
|
|
|
|
|
|
|||||||||
|
$ |
0.24 |
|
|
$ |
(0.76 |
) |
|
$ |
(0.19 |
) |
|
$ |
(1.71 |
) |
|
|
|
|
|
|
|
|
|
|||||||||
Weighted average shares outstanding - diluted |
|
40,617 |
|
|
|
31,404 |
|
|
|
31,469 |
|
|
|
31,300 |
|
Condensed Consolidated Balance Sheets (In thousands) |
||||||
|
(Unaudited) |
|
(Audited) |
|||
|
|
|
|
|||
|
|
|
|
|||
Assets: |
|
|
|
|||
|
|
|
|
|||
Cash and cash equivalents |
$ |
57,741 |
|
$ |
17,658 |
|
Restricted cash |
|
5,677 |
|
|
6,396 |
|
Accounts receivable |
|
26,273 |
|
|
28,902 |
|
Government grants receivable |
|
— |
|
|
4,335 |
|
Refundable income taxes |
|
— |
|
|
22,435 |
|
Assets held for sale |
|
521 |
|
|
4,856 |
|
Other current assets |
|
19,683 |
|
|
15,364 |
|
Property and equipment, net |
|
755,626 |
|
|
771,192 |
|
Operating lease right-of-use assets |
|
209,264 |
|
|
217,072 |
|
Other assets |
|
99,850 |
|
|
100,151 |
|
|
|
|
|
|||
Total Assets |
$ |
1,174,635 |
|
$ |
1,188,361 |
|
|
|
|
|
|||
Liabilities and Shareholders' Equity: |
|
|
|
|||
|
|
|
|
|||
Accounts payable |
$ |
38,335 |
|
$ |
35,781 |
|
Taxes other than income taxes |
|
19,219 |
|
|
19,566 |
|
Other current liabilities |
|
78,496 |
|
|
80,152 |
|
Short-term borrowings |
|
46,628 |
|
|
47,346 |
|
Current portion of finance lease obligations |
|
2,489 |
|
|
2,561 |
|
Current portion of operating lease obligations |
|
16,291 |
|
|
16,795 |
|
Current maturities of long-term debt |
|
11,077 |
|
|
10,967 |
|
Finance lease obligations |
|
16,116 |
|
|
17,192 |
|
Operating lease obligations |
|
207,713 |
|
|
216,064 |
|
Long-term debt |
|
203,720 |
|
|
204,177 |
|
Deferred income taxes |
|
25,125 |
|
|
26,183 |
|
Other long-term obligations |
|
56,693 |
|
|
57,963 |
|
Equity |
|
452,733 |
|
|
453,614 |
|
|
|
|
|
|||
Total Liabilities and Shareholders' Equity |
$ |
1,174,635 |
|
$ |
1,188,361 |
Business Segment Information (Unaudited) (In thousands) |
||||||||||||||||
|
Theatres |
|
Hotels/
|
|
Corporate
|
|
Total |
|||||||||
13 Weeks Ended |
|
|
|
|
|
|
|
|||||||||
Revenues |
$ |
129,437 |
|
|
$ |
69,001 |
|
|
$ |
117 |
|
|
$ |
198,555 |
|
|
Operating income (loss) |
|
16,430 |
|
|
|
6,817 |
|
|
|
(4,354 |
) |
|
|
18,893 |
|
|
Depreciation and amortization |
|
11,863 |
|
|
|
4,801 |
|
|
|
88 |
|
|
|
16,752 |
|
|
Adjusted EBITDA |
|
28,753 |
|
|
|
11,833 |
|
|
|
(3,286 |
) |
|
|
37,300 |
|
|
|
|
|
|
|
|
|
|
|||||||||
13 Weeks Ended |
|
|
|
|
|
|
|
|||||||||
Revenues |
$ |
52,301 |
|
|
$ |
40,151 |
|
|
$ |
95 |
|
|
$ |
92,547 |
|
|
Operating loss |
|
(18,215 |
) |
|
|
(2,239 |
) |
|
|
(5,656 |
) |
|
|
(26,110 |
) |
|
Depreciation and amortization |
|
13,385 |
|
|
|
5,047 |
|
|
|
62 |
|
|
|
18,494 |
|
|
Adjusted EBITDA |
|
(441 |
) |
|
|
3,333 |
|
|
|
(4,108 |
) |
|
|
(1,216 |
) |
|
|
|
|
|
|
|
|
|
|||||||||
26 Weeks Ended |
|
|
|
|
|
|
|
|||||||||
Revenues |
$ |
208,928 |
|
|
$ |
121,658 |
|
|
$ |
211 |
|
|
$ |
330,797 |
|
|
Operating income (loss) |
|
8,410 |
|
|
|
3,843 |
|
|
|
(10,157 |
) |
|
|
2,096 |
|
|
Depreciation and amortization |
|
24,054 |
|
|
|
9,751 |
|
|
|
178 |
|
|
|
33,983 |
|
|
Adjusted EBITDA |
|
33,532 |
|
|
|
14,217 |
|
|
|
(7,098 |
) |
|
|
40,651 |
|
|
|
|
|
|
|
|
|
|
|||||||||
26 Weeks Ended |
|
|
|
|
|
|
|
|||||||||
Revenues |
$ |
74,863 |
|
|
$ |
68,276 |
|
|
$ |
195 |
|
|
$ |
143,334 |
|
|
Operating loss |
|
(43,854 |
) |
|
|
(7,947 |
) |
|
|
(9,970 |
) |
|
|
(61,771 |
) |
|
Depreciation and amortization |
|
26,171 |
|
|
|
10,174 |
|
|
|
128 |
|
|
|
36,473 |
|
|
Adjusted EBITDA |
|
(14,171 |
) |
|
|
3,038 |
|
|
|
(7,552 |
) |
|
|
(18,685 |
) |
Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues. |
Supplemental Data (Unaudited) (In thousands) |
|||||||||||||||||
|
|
13 Weeks Ended |
|
26 Weeks Ended |
|||||||||||||
Consolidated |
|
|
|
|
|
|
|
|
|||||||||
Net cash flow provided by (used in) operating activities |
|
$ |
48,757 |
|
|
$ |
3,302 |
|
|
$ |
55,228 |
|
|
$ |
(9,681 |
) |
|
Net cash flow provided by (used in) investing activities |
|
|
(8,372 |
) |
|
|
(6,297 |
) |
|
|
(11,475 |
) |
|
|
(3,745 |
) |
|
Net cash flow provided by (used in) financing activities |
|
|
(1,220 |
) |
|
|
5,222 |
|
|
|
(4,389 |
) |
|
|
14,468 |
|
|
Capital expenditures |
|
|
(9,779 |
) |
|
|
(4,670 |
) |
|
|
(16,341 |
) |
|
|
(6,195 |
) |
Reconciliation of Net earnings (loss) to Adjusted EBITDA (Unaudited) (In thousands) |
||||||||||||||||
|
13 Weeks Ended |
|
26 Weeks Ended |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net earnings (loss) attributable to |
$ |
8,960 |
|
|
$ |
(23,366 |
) |
|
$ |
(5,942 |
) |
|
$ |
(51,496 |
) |
|
Add (deduct): |
|
|
|
|
|
|
|
|||||||||
Investment (income) loss |
|
459 |
|
|
|
(120 |
) |
|
|
727 |
|
|
|
(160 |
) |
|
Interest expense |
|
4,063 |
|
|
|
4,907 |
|
|
|
8,155 |
|
|
|
9,750 |
|
|
Other expense (income) |
|
584 |
|
|
|
628 |
|
|
|
1,161 |
|
|
|
1,256 |
|
|
(Gain) loss on disposition of property, equipment and other assets |
|
69 |
|
|
|
164 |
|
|
|
(355 |
) |
|
|
(2,040 |
) |
|
Equity (earnings) losses from unconsolidated joint ventures |
|
(7 |
) |
|
|
— |
|
|
|
134 |
|
|
|
— |
|
|
Income tax expense (benefit) |
|
4,765 |
|
|
|
(8,323 |
) |
|
|
(1,784 |
) |
|
|
(19,081 |
) |
|
Depreciation and amortization |
|
16,752 |
|
|
|
18,494 |
|
|
|
33,983 |
|
|
|
36,473 |
|
|
Share-based compensation expenses (a) |
|
1,655 |
|
|
|
2,668 |
|
|
|
4,572 |
|
|
|
4,152 |
|
|
Impairment charges (b) |
|
— |
|
|
|
3,732 |
|
|
|
— |
|
|
|
3,732 |
|
|
Government grants (c) |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,271 |
) |
|
Adjusted EBITDA |
$ |
37,300 |
|
|
$ |
(1,216 |
) |
|
$ |
40,651 |
|
|
$ |
(18,685 |
) |
(a) |
Non-cash charges related to share-based compensation programs. |
(b) |
Non-cash impairment charges related to surplus theatre real estate. |
(c) |
Reflects a nonrecurring state government grant awarded to our theatres for COVID-19 pandemic relief. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220802006147/en/
(414) 905-1036
investors@marcuscorp.com
Source:
FAQ
What are the key financial results for Marcus Corporation in Q2 2022?
When is the cash dividend for MCS scheduled to be paid?
How did Marcus Theatres perform during the second quarter of fiscal 2022?
What is the Adjusted EBITDA for Marcus Corporation in Q2 2022?